The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Caption Newly release study data indicates that after two years, children who wore their SightGlass Vision Diffusion Optics Technology-enabled spectacles full time, including not removing them for ...

DelveInsight Analysis: The Myopia Treatment Devices market size is expected to grow at a CAGR of 7.57% during the study ...